Drug Pipeline

Showing 1–6 of 7 results

Filter By

Clear Filters

  1. WATCH: New Developments in Restoring CFTR Function, Feb. 2016

    By Christina Roman February 17, 2016

    Drs. Drucy Borowitz and Manu Jain share new developments in drugs that will treat the underlying cause of cystic fibrosis.

  2. WATCH: New Developments in Drugs to Restore Airway Surface Liquid, March 2016

    By Christina Roman March 15, 2016

    Dr. John P. Clancy shares new developments in drugs that restore airway surface liquid in the lungs of people with cystic fibrosis, making it easier to clear mucus.

  3. WATCH: New Developments in Drugs to Reduce Inflammation, Feb. 2016

    By Christina Roman February 29, 2016

    Dr. James Chmiel shares new developments in drugs to reduce inflammation in the lungs and help prevent lung damage.

  4. WATCH: New Developments in Drugs to Reduce Infection, March 2016

    By Christina Roman March 29, 2016

    Dr. Jennifer Taylor-Cousar shares new developments in drugs that fight infections in the lungs of people with cystic fibrosis.

  5. I Better Start Saving for 100 Days in Hawaii

    By Susie Rider June 7, 2016

    When my 8-year-old daughter with CF found out that the disease is potentially fatal, I was grateful for her optimistic views on life and death. But deep down, I was saddened with the thought of a cure being so far away that I wouldn’t be around to see it. Today, my fears have dwindled.

  6. News

    FDA Expands Use of Orkambi® to Children Ages 6 to 11 With CF

    September 28, 2016

    The U.S. Food and Drug Administration (FDA) approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 6 to 11, who have two copies of the F508del mutation.